ARCHIVES

FDA Approves Lilly’s Alimta For Metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 27 No. 8 | August 27, 2004

Download PDF Visit The Full Archive

Related Articles

Oblimersen Combination Improves CLL Survival

December 28, 2007

Funding Opportunities

October 18, 2002

Non-Profit Spent $1.3 Million On Consultants.

March 28, 2008

Cancer Telethon Attracts Small Audience, Generates Expectations-And Questions.

September 12, 2008

NCI-supported meeting included tobacco industry representatives in dialogue on ethics.

October 29, 2004

R01 Payline To Increase From 21st to 22nd Percentile; Barcelona Hospital Wins BMS Cancer Research Grant

June 14, 2002